Related Experiment Video
Updated: Aug 12, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Decreased interleukin-2 receptor beta chain expression by peripheral blood lymphocytes in chronic liver disease
1Third Department of Internal Medicine, Ehime University School of Medicine, Japan.
Insights
Natural killer (NK) cell activity declines in chronic liver disease due to reduced interleukin-2 receptor beta chain (IL-2R beta) expression on peripheral blood lymphocytes (PBL). This decrease correlates with diminished NK cell function in patients with viral hepatitis, cirrhosis, and liver cancer.
Area of Science:
- Immunology
- Hepatology
- Cell Biology
Background:
- Natural killer (NK) cell activity is crucial for immune surveillance and is often impaired in chronic liver diseases.
- The interleukin-2 receptor beta chain (IL-2R beta) plays a role in lymphocyte activation and function.
Purpose of the Study:
- To investigate the relationship between NK activity and IL-2R beta expression in patients with chronic liver disease.
- To determine the specific cell populations expressing IL-2R beta in the context of liver pathology.
Main Methods:
- Peripheral blood lymphocytes (PBL) from patients and controls were analyzed using flow cytometry.
- Expression of IL-2R beta was assessed using a specific monoclonal antibody.
- Two-colour flow cytometry identified IL-2R beta expression on CD8+ and CD16+ cells, including NK cells (CD8dull+).
Main Results:
- IL-2R beta expression on PBL was significantly decreased in patients with chronic viral hepatitis, liver cirrhosis, and hepatocellular carcinoma compared to healthy controls.
- Reduced IL-2R beta expression was observed in chronic active hepatitis compared to chronic persistent hepatitis.
- IL-2R beta expression on CD8+ and CD16+ cells, particularly NK cells, was significantly lower in chronic liver disease patients.
- A strong positive correlation was found between NK activity and IL-2R beta+ PBL percentage, and between NK activity and PBL co-expressing IL-2R beta and CD16.
Conclusions:
- Decreased IL-2R beta expression on PBL is associated with diminished NK activity in chronic liver disease.
- This finding suggests a potential mechanism for immune dysfunction in conditions like viral hepatitis, cirrhosis, and liver cancer.
- Targeting IL-2R beta expression could be a future avenue for therapeutic intervention in chronic liver diseases.
Abstract:
To investigate the decrease in natural killer (NK) activity in chronic liver disease, interleukin-2 receptor beta chain (IL-2R beta) expression was assessed by peripheral blood lymphocytes (PBL) using flow cytometry and an IL-2R beta chain-specific mouse monoclonal antibody. The percentage of IL-2R beta chain-positive PBL was significantly decreased in patients with chronic viral hepatitis, liver cirrhosis and hepatocellular carcinoma in comparison with normal controls (P less than 0.01). Among chronic viral hepatitis patients, it was significantly less in those with chronic active hepatitis than in those with chronic persistent hepatitis (P less than 0.05). Two-colour flow cytometry revealed that the IL-2R beta chain was mainly expressed by CD8+ or CD16+ cells in both the controls and the liver disease patients. CD8dull+ cells (NK cells) constituted more than 60% of the CD8+ cells expressing the IL-2R beta chain. Expression of the IL-2R beta chain with CD8 or CD16 was also significantly decreased in chronic liver disease patients compared with controls. In chronic viral hepatitis, there was a significant correlation between NK activity and the percentage of IL-2R beta+ PBL (P less than 0.001, r = 0.916), as well as between NK activity and the percentage of PBL co-expressing both the IL-2R beta chain and CD16 (P less than 0.001, r = 0.850). These findings suggest that decreased expression of the IL-2R beta chain by PBL may result in diminished NK activity in chronic liver disease.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Ulcerative Colitis
Cirrhosis II: Pathophysiology

